logo
Select company
Select metric
$ -41.65MConsolidated Income
VS
Market
21
Sector
42
Industry
54
History
93
$ 0.51Close
$ 0.25 - $ 1.2 52-Week Range
Ticker Information

Ticker

RLYB

Company Name

RALLYBIO CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RALLYBIO CORP - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RLYB - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -41.65M
3/31/2025$ -48.19M
12/31/2024$ -57.77M
9/30/2024$ -66.97M
6/30/2024$ -73.88M
3/31/2024$ -76.28M
12/31/2023$ -74.56M
9/30/2023$ -70.53M
6/30/2023$ -70.52M
3/31/2023$ -69.47M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RALLYBIO CORP's latest trailing twelve months (TTM) Cons. Inc. stands at $ -26.45M.
  • Over the past 5 years, RALLYBIO CORP's average Cons. Inc. has been $ -59.73M.
  • The median Cons. Inc. for RALLYBIO CORP during this period was $ -64.76M
  • RALLYBIO CORP reached its highest Cons. Inc. over the past 5 years at $ -26.45M.
  • The lowest Cons. Inc. recorded by RALLYBIO CORP in the same timeframe $ -76.28M

RALLYBIO CORP's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
ICU : SEASTAR MEDICAL HOLDING CORP $ -14.67MLEXX : LEXARIA BIOSCIENCE CORP $ -11.4MLYRA : LYRA THERAPEUTICS INC $ -38.84MLSTA : LISATA THERAPEUTICS INC $ -18.92MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.56MPULM : PULMATRIX INC $ -7.93MAPRE : APREA THERAPEUTICS INC $ -13.85MBRTX : BIORESTORATIVE THERAPIES INC $ -10.72MIBIO : IBIO INC $ -18.38MERNA : ERNEXA THERAPEUTICS INC $ -43.7M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

RLYB - Consolidated Income, Last 5 years

$ -76.28M

Minimum

Mar 31, 2024

$ -26.45M

Maximum

Dec 31, 2020

$ -59.73M

Average

$ -64.76M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M